You are here

Novartis

Novartis plots Precision attack on sickle cell, paying $75M and putting up $1.4B in biobucks to form in vivo gene editing pact

Fierce Biotech

Wed, 06/22/22 - 10:23 am

Precision Biosciences

sickle cell disease

beta thalassemia

Novartis' recent Gilenya patent win slips away after appeals court reverses its own prior verdict

Fierce Pharma

Tue, 06/21/22 - 11:45 pm

multiple sclerosis

More drug, fewer jabs: Novartis' Sandoz eyes EMA nod for high-concentration Humira copy

Fierce Pharma

Mon, 06/20/22 - 10:37 am

autoimmune disease

Taking Charge—biotechs already approaching Novartis to partner on 'game changing' CAR-T platform

Fierce Biotech

Tue, 06/14/22 - 11:18 am

Novartis’ Sandoz Launches Biosimilars Awareness Campaign to Improve Biosimilars Adoption Worldwide

Xtalks

Wed, 06/8/22 - 11:04 pm

Novartis Combo could be New Standard of Care for Pediatric Glioma Patients

BioSpace

Wed, 06/8/22 - 10:42 am

clinical trials

In age discrimination suit, US agency sues Novo Nordisk for filling job with younger, less qualified applicant

Fierce Pharma

Wed, 06/8/22 - 10:21 am

age discrimination

Novartis is latest victim of cyberattack, but claims no confidential data compromised — report

Endpoints

Mon, 06/6/22 - 11:49 pm

Novartis resumes remote business in Ukraine after safety protocol review

Endpoints

Thu, 06/2/22 - 07:22 pm

Novartis' surprise radiotherapy production halt nearing an end as FDA docs shed light on plant woes

Fierce Pharma

Thu, 06/2/22 - 10:20 am

Amgen eyes swift move to ph3 for cardiovascular drug olpasiran

Pharmaforum

Wed, 06/1/22 - 09:33 am

clinical trials

cardiovascular disease

Novartis' Sandoz founds new initiative to expand biosimilar use more globally

Endpoints

Tue, 05/31/22 - 11:51 pm

Novartis (NVS) Wins FDA Nod for Label Expansion of Kymriah

Yahoo/Zacks.com

Tue, 05/31/22 - 10:41 am

relapsed or refractory follicular lymphoma

Abbvie to become the biggest of pharmas in 2028

EP Vantage

Mon, 05/30/22 - 10:13 am

Bristol Myers Squibb

ASCO: Novartis eyes full nod for Gleevec follow-on Scemblix thanks to new leukemia data

Fierce Pharma

Fri, 05/27/22 - 10:21 am

chronic myeloid leukemia

Bristol Myers Squibb sues Novartis for royalties surrounding the use of transgenic mice

Endpoints

Tue, 05/24/22 - 04:36 pm

Bristol Myers Squibb

transgenic mice

Long-expected UK layoffs imminent for Novartis following sale

Endpoints

Tue, 05/17/22 - 10:28 pm

drug manufacturing

Greece goes on offensive against Novartis, filing a lawsuit in aftermath of bribery scheme

Endpoints

Tue, 05/17/22 - 10:22 pm

Big pharma’s biggest spenders revealed

EP Vantage

Tue, 05/17/22 - 10:29 am

Bristol Myers Squibb

Novartis' Sandoz strikes at Roche with first US generic of blockbuster Esbriet

Fierce Pharma

Fri, 05/13/22 - 10:46 am

idiopathic pulmonary fibrosis

Pages